Neil Buckley

Advisor

Neil Buckley is an Advisor at Raven. Since joining, Neil has been involved in the creation of six companies incubated within Raven, including Lusaris Therapeutics, Eliem Therapeutics ($ELYM), Aerovate Therapeutics ($AVTE), Imbria Pharmaceuticals, and Athenen Therapeutics (acquired by Eliem). Neil was previously the Vice President, CMC at Raven and worked across new company formation and in support of portfolio companies. Previously, Neil was Director, Business Development and Project Management at CiVentiChem (acquired by Sterling Pharma Solutions). He holds a MS from Northeastern University and a BA from Hamilton College.